Skip to content

Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors

Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06924788
Acronym
VSMART
Enrollment
25
Registered
2025-04-11
Start date
2025-07-24
Completion date
2026-12-31
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Keywords

Breast Cancer

Brief summary

In a sample of Alabama breast cancer survivors, the proposed study tests the feasibility and acceptability of a stress management program that has been shown to improve health and wellbeing in a general population of patients with a history of breast cancer. The study will also get feedback (e.g., implementation barriers and facilitators) from relevant stakeholders.

Interventions

BEHAVIORALVideo-Conferenced Stress Management and Relaxation Training (VSMART)

10 week stress management group discussions

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Breast cancer survivor (stage I-III) * English fluency * Living in neighborhood with high deprivation index

Exclusion criteria

* No English fluency * No history of breast cancer * Living in neighborhood with low deprivation index

Design outcomes

Primary

MeasureTime frameDescription
Percentage of people enrolled out of contactedAt time of enrollment30% enrolled of contacted for feasibility threshold

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChloe Taub, PhD

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026